|
E2F2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.151600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.245200E-01 |
| Normal-vs-Stage2 |
1.036630E-01 |
| Normal-vs-Stage3 |
5.356000E-01 |
| Normal-vs-Stage4 |
7.406800E-01 |
| Stage1-vs-Stage2 |
9.009300E-04 |
| Stage1-vs-Stage3 |
3.102800E-01 |
| Stage1-vs-Stage4 |
8.060000E-01 |
| Stage2-vs-Stage3 |
4.279700E-02 |
| Stage2-vs-Stage4 |
2.369700E-02 |
| Stage3-vs-Stage4 |
6.126800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.283600E-01 |
| Normal-vs-AfricanAmerican |
2.697000E-01 |
| Normal-vs-Asian |
6.428800E-01 |
| Caucasian-vs-AfricanAmerican |
1.627840E-01 |
| Caucasian-vs-Asian |
5.005000E-01 |
| AfricanAmerican-vs-Asian |
2.074800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.888200E-01 |
| Normal-vs-Female |
5.937800E-01 |
| Male-vs-Female |
7.285600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.954200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.172600E-01 |
| Normal-vs-Age(61-80Yrs) |
7.869200E-01 |
| Normal-vs-Age(81-100Yrs) |
6.841800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.399500E-04 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.801200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.986600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.751800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.533220E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.824200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.056200E-01 |
| Classical-VS-Follicular |
8.759600E-03 |
| Classical-VS-Other |
6.668800E-01 |
| Classical-VS-Normal |
7.678200E-01 |
| Tall-VS-Follicular |
5.745700E-02 |
| Tall-VS-Other |
5.295600E-01 |
| Tall-VS-Normal |
9.608600E-01 |
| Follicular-VS-Other |
6.597600E-01 |
| Follicular-VS-Normal |
1.908230E-01 |
| Other-VS-Normal |
5.544200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.857600E-01 |
| Normal-vs-N1 |
4.665200E-01 |
| N0-vs-N1 |
6.315200E-01 |
|
|
